Advances in Hematology
Total Page:16
File Type:pdf, Size:1020Kb
ADVANCES IN HEMATOLOGY Current Developments in the Management of Hematologic Disorders Hematology Section Editor: Craig M. Kessler, MD What Hematologists Need to Know About Acute Hepatic Porphyria Manisha Balwani, MD, MS Associate Professor Department of Genetics and Genomic Sciences Icahn School of Medicine at Mount Sinai New York, New York H&O What is porphyria? H&O How common is acute hepatic porphyria? MB The porphyrias encompass a group of inherited MB Based on estimates from Western Europe, the metabolic disorders that result from a deficiency of one of combined prevalence of the acute hepatic porphyrias the enzymes in the heme biosynthetic pathway. These are among the white population is approximately 1 in genetic disorders; they can be inherited in an autosomal 200,000. These disorders are more common in certain dominant or recessive X-linked pattern; or they may be parts of the world because of founder mutations. For sporadic, as with porphyria cutanea tarda. example, the carrier frequency of acute intermittent porphyria is much higher in the Scandinavian countries, H&O How many types of porphyria exist? and variegate porphyria is much more common in South Africa.1 MB There are 8 different kinds of porphyria. These may be Even where the incidence is high, symptoms related classified as hepatic or erythropoietic based on the primary to these disorders remain rare. In fact, most patients who site of accumulation of porphyrins, but more commonly inherit a genetic change do not manifest symptoms of the they are classified clinically as acute or cutaneous. The acute disorder—the disease remains latent in a vast majority of hepatic porphyrias include acute intermittent porphyria these patients. Based on studies from Europe, we have (the most common form), hereditary coproporphyria, and estimated that only about 10% of patients who have a variegate porphyria, which are autosomal dominant in mutation in one of these genes will actually present with inheritance. Aminolevulinic acid dehydratase deficiency symptoms. In fact, a more recent study using genomic porphyria is autosomal recessive and very rare, with fewer and exomic databases suggests that having a mutation than 10 cases reported worldwide. in one of these genes is much more common than we The cutaneous porphyrias include porphyria cutanea initially thought, making the penetrance of this disorder tarda, which is the most common form; erythropoietic much lower.2 protoporphyria; X-linked protoporphyria; and congenital erythropoietic porphyria. These can present with blistering H&O Could you talk in more detail about the skin lesions or with nonblistering photosensitivity. Her- causes of acute hepatic porphyria? editary coproporphyria and variegate porphyria also can present with blistering skin lesions similar to those MB As I mentioned, a genetic change leads to a deficiency seen in porphyria cutanea tarda. Patients with cutaneous in one of the enzymes in the heme biosynthetic pathway. porphyria rarely present to hematologists, which is why I Because these are almost always autosomal dominant dis- am focusing on the acute hepatic porphyrias. orders, patients have approximately half-normal enzyme 858 Clinical Advances in Hematology & Oncology Volume 14, Issue 11 November 2016 Uncontrolled Complement Amplication Succinyl Coenzyme A Glycine Hematology X-linked protoporphyria, X-linked sideroblastic anemia Aminolevulinic acid synthase Negative feedback δ-Aminolevulinic acid Aminolevulinic acid dehydratase deciency porphyria Aminolevulinic acid dehydratase Porphobilinogen Acute intermittent porphyria Hydroxymethylbilane synthase Hydroxymethylbilane Congenital erythropoietic porphyria Uroporphyrinogen III synthase Nonenzymatic Uroporphyrinogen III Uroporphyrinogen I—uroporphyrin I Porphyria cutanea tarda, hepatoerythropoietic porp hyria Uroporphyrinogen decarboxylase Coproporphyrinogen III Coproporphyrinogen I—coproporphyrin I Hereditary coproporphyria Coproporphyrinogen oxidase Protoporphyrinogen IX Variegate porphyria Protoporphyrinogen oxidase Protoporphyrin IX Erythropoietic protoporphyria Ferrochelatase Negative feedback Heme Figure. The heme biosynthetic pathway. Enzymes are in italics. activity. Under normal circumstances, this is sufficient managed correctly. Delays in diagnosis and treatment for heme synthesis. The presence of certain precipitating may result in chronic complications that can be very factors, however, can lead to symptomatic disease. The debilitating for patients. most common precipitating factors are drugs, fasting, hormonal changes, stress, and illness. Women are much H&O What are the symptoms of porphyria, and more likely than men to manifest symptoms, presumably what complications can occur? because of hormonal factors. All of these factors markedly increase the demand MB One of the most common symptoms is acute for hepatic heme, and the decreased hepatic free heme abdominal pain that is poorly localized and very induces the synthesis of δ-aminolevulinic acid synthase severe. Because the pain is neuropathic, it often is not 1 (ALAS1)—the first enzyme in the heme biosynthetic accompanied by fever or leukocytosis. Patients also may pathway—by a negative feedback mechanism (Figure). experience nausea, vomiting, constipation, or pain in the Because of the approximately half-normal enzyme activity chest or back. They also can have significant autonomic in these acute hepatic porphyrias, the marked overexpres- dysfunction, including tachycardia and hypertension. sion of ALAS1 results in the increased production and Patients also may develop paresis or acute motor subsequent accumulation of the neurotoxic porphyrin neuropathy, and may experience changes in mental status, precursors, aminolevulinic acid (ALA) and urine porpho- such as behavioral changes, agitation, or hallucinations. bilinogen (PBG). These porphyrin precursors are thought If patients do not receive appropriate treatment, there to be neurotoxic and responsible for the multisystemic is a possibility that neuropathy could progress and even manifestations of this disorder. lead to respiratory paralysis. Recent reports have shown that during acute attacks, some patients develop posterior H&O What is the prognosis for someone with reversible encephalopathy syndrome, which can be acute porphyria? diagnosed on magnetic resonance imaging of the brain and can give a clue to the diagnosis. One important MB The overall prognosis is good because specific treat- thing to note is that no sign or symptom is universal, and ment is available, but symptoms must be recognized and presentations are often atypical. Clinical Advances in Hematology & Oncology Volume 14, Issue 11 November 2016 859 Another important early sign of this disorder is avoid the triggering factors that could precipitate acute hyponatremia. This is often seen when patients present attacks. with acute attacks, and can be one of the first clues leading Hematology to diagnosis. Hyponatremia presumably occurs because H&O Does porphyria often get confused with of the syndrome of inappropriate antidiuretic hormone other diseases? secretion (SIADH) or because of loss of sodium in the gastrointestinal tract or kidneys. It is very important to MB The most common presenting symptoms of this monitor patients with hyponatremia because they can disorder—abdominal pain, nausea, and vomiting—are develop seizures. common, nonspecific symptoms. As you can imagine, this Additional findings that can lead a physician to is a major reason why the disorder is often misdiagnosed suspect porphyria include new-onset hypertension in and underdiagnosed. We often come across patients who a young patient, proximal muscle weakness, or dark or have been misdiagnosed for many years. Some of the more reddish-brown urine.3 common misdiagnoses are appendicitis and cholecystitis; other patients are told they have a urinary tract infection, H&O How is the disease diagnosed? colitis, or another common condition. Many patients actually have multiple surgeries before the diagnosis is MB The most important diagnostic test for acute hepatic established. porphyria is PBG. This can be done on a spot sample of urine; there is no need to waste valuable time by collecting H&O What treatments are used for acute a 24-hour sample. If urine PBG is elevated, the patient porphyria? has an acute hepatic porphyria. This is a highly sensitive test because urine PBG typically is elevated during an MB The most important step is to stabilize patients, and acute attack. address symptoms such as nausea, vomiting, hypertension, Second-line testing is available to determine the and electrolyte imbalances such as hyponatremia. Patients specific type of acute porphyria, although knowing also should be treated for their pain, which is severe—I the type is not necessary at the time of initial diagnosis would like to emphasize that many of these patients are because treatment for acute symptoms for all the forms undertreated for their pain. All patients need to have a is identical. careful history taken to identify what triggering factors Genetic testing can be used as a confirmatory test might be involved. All offending drugs and other factors for the diagnosis. Gene sequencing is available for all should be removed. of the genes involved in acute hepatic porphyria. This In the past, 10% dextrose solution was used as first- is important not just to establish the diagnosis in the line treatment for these patients, but more recently we patient, but for testing family members. have switched to